Oracle Introduces Oracle Clinical Development Analytics
Redwood Shores, CA
Oracle has announced its Oracle Clinical Development Analytics, a component of a larger suite of business intelligence solutions that span clinical development, pre- and post-marketing surveillance and health care, which are designed to provide insights for more informed decision making.
Built on the Oracle Business Intelligence Suite Enterprise Edition Plus, Oracle Clinical Development Analytics is intended to assist life sciences organizations deliver actionable, near real-time insights across the clinical development process, including both active and previously completed trials.
“Life Sciences organizations require systems that can improve the quality and timeliness of their clinical information to enhance the overall effectiveness of their programs,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle Clinical Development Analytics meets the industry need for a business intelligence application that helps life sciences executives, managers, and team members to make decisions based on current, consistent performance management information that has historically been dispersed across numerous sources and technologies.”
The application can help accelerate study progress and makes it possible for companies to achieve database lock faster. It helps make it easier to identify non-performing sites and enables greater transparency between sponsors and CROs.
With the application’s pre-built clinical warehouse and ad-hoc report builder help end users to build their own reports based on pre-calculated metrics. The centralized warehousing architecture can help to more effectively control IT costs by eliminating the need for multiple, disparate reporting systems.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
